/IZAFE-B.ST
IZAFE-B.ST Stock - iZafe Group AB (publ)
Healthcare|Medical - Instruments & SuppliesSTO
$0.47+4.73%
+$0.02 (+4.73%) • Dec 23
69
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.58
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.51
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for IZAFE-B.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.46 – $0.47
TARGET (TP)$0.53
STOP LOSS$0.43
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.12
52W High$0.80
52W Low$0.20
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $7.95M | $1.82M | $729,000 | $442,000 | $8.90M |
| Gross Profit | $-1,634,000 | $293,000 | $123,000 | $-1,138,000 | $7.64M |
| Gross Margin | -20.5% | 16.1% | 16.9% | -257.5% | 85.9% |
| Operating Income | $-19,425,000 | $-35,635,000 | $-23,404,000 | $-33,273,000 | $-12,112,000 |
| Net Income | $-20,509,000 | $-32,175,000 | $-23,526,000 | $-36,275,000 | $-12,754,000 |
| Net Margin | -257.8% | -1765.9% | -3227.2% | -8207.0% | -143.2% |
| EPS | $-0.07 | $-0.14 | $-0.29 | $-0.78 | $-0.37 |
Company Overview
iZafe Group AB (publ), a life-science company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated drug dispenser that handles dose bags, facilitates and enables independent medication, and reminds and alerts if the current dose is not taken at the right time. It serves consumers, and public and private-sector care providers in Sweden, the Nordic region, and internationally. The company was formerly known as MediRätt AB (publ) and changed its name to iZafe Group AB (publ) in May 2019. iZafe Group AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
IZAFE-B.STBeat Rate
33%
Last 3 quarters
Avg Surprise
-10.8%
EPS vs Estimate
Beats / Misses
1/2
Last 12 quarters
Latest EPS
$-0.01
Q3 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 30, 2025 | — | $-0.01 | — | — |
Q3 2025 | Aug 29, 2025 | — | $-0.01 | — | — |
Q2 2025 | Apr 25, 2025 | — | $-0.01 | — | — |
Q1 2025 | Feb 14, 2025 | — | $-0.02 | — | — |
Q4 2024 | Nov 1, 2024 | — | $-0.02 | — | — |
Q3 2024 | Aug 30, 2024 | — | $-0.02 | — | — |
Q2 2024 | Apr 26, 2024 | — | $-0.02 | — | — |
Q1 2024 | Feb 9, 2024 | — | $-0.07 | — | — |
Q4 2023 | Nov 17, 2023 | — | $-0.02 | — | — |
Q3 2023 | Aug 25, 2023 | — | $-0.02 | — | — |
Q2 2023 | May 12, 2023 | — | $-0.03 | — | — |
Q1 2023 | Feb 3, 2023 | — | $-0.05 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.08 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.07 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.10 | — | — |
Q1 2022 | Feb 18, 2022 | $-0.15 | $-0.12 | +18.8% | ✓ BEAT |
Q4 2021 | Nov 29, 2021 | $-0.15 | $-0.17 | -17.8% | ✗ MISS |
Q3 2021 | Aug 4, 2021 | — | $-0.24 | — | — |
Q2 2021 | Apr 29, 2021 | $-0.21 | $-0.28 | -33.3% | ✗ MISS |
Q1 2021 | Feb 19, 2021 | — | $-0.28 | — | — |
Latest News
Loading news...
Frequently Asked Questions about IZAFE-B.ST
What is IZAFE-B.ST's current stock price?
iZafe Group AB (publ) (IZAFE-B.ST) is currently trading at $0.47 per share. The stock has moved +4.73% today.
What is the analyst price target for IZAFE-B.ST?
No analyst price targets are currently available for this stock.
What sector is iZafe Group AB (publ) in?
iZafe Group AB (publ) operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the STO exchange.
What is IZAFE-B.ST's market cap?
iZafe Group AB (publ) has a market capitalization of $0.14 billion, making it a small-cap company.
Does IZAFE-B.ST pay dividends?
No, iZafe Group AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorANNX.ST
Annexin Pharmaceuticals AB (publ)
$19.00
Mkt Cap: $0.1B
BIOWKS.ST
Bio-Works Technologies AB (publ)
$2.25
Mkt Cap: $0.2B
CLS-B.ST
Clinical Laserthermia Systems AB (publ)
$7.00
Mkt Cap: $0.2B
ERMA.ST
Enorama Pharma AB (publ)
$2.30
Mkt Cap: $0.2B
INIT.ST
Initiator Pharma A/S
$2.93
Mkt Cap: $0.2B
INTEG-B.ST
Integrum AB (publ)
$10.06
Mkt Cap: $0.2B
ISOFOL.ST
Isofol Medical AB (publ)
$0.72
Mkt Cap: $0.2B
LIPUM.ST
Lipum AB (publ)
$14.55
Mkt Cap: $0.3B
QLINEA.ST
Q-linea AB (publ)
$22.36
Mkt Cap: $0.1B
SENZA.ST
SenzaGen AB
$5.98
Mkt Cap: $0.2B
Explore stocks similar to IZAFE-B.ST for comparison